Announcement on Abnormal Stock Trading Fluctuations

Wanbang Pharmaceutical Co., Ltd.·July 21, 2026·2 pages

✨ AI Summary

Anbang Wanbang Pharmaceutical Technology Co., Ltd. announces abnormal stock trading fluctuations, with its stock price falling by over 30% in two consecutive trading days. The company has conducted self-checks and confirmed no undisclosed material information, no violation of fair disclosure, and normal business operations. The company will disclose its interim report on August 29, 2026.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 301520

Stock Abbreviation: Wanbang Pharmaceutical

Announcement No.: 2026-026

Anbang Wanbang Pharmaceutical Technology Co., Ltd.

Announcement on Abnormal Stock Trading Fluctuations

The Company and the entire Board of Directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or major omissions.

I. Description of Abnormal Stock Trading Fluctuations

Anbang Wanbang Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company") (Stock Abbreviation: Wanbang Pharmaceutical, Stock Code: 301520) experienced a cumulative deviation from its closing price of over 30% for two consecutive trading days (July 20, 2026, and July 21, 2026). In accordance with the "Trading Rules of the Shenzhen Stock Exchange" and other relevant regulations, this constitutes an abnormal stock trading fluctuation.

II. Company's Attention and Verification of the Situation

In response to the abnormal stock trading fluctuations, the Company's Board of Directors conducted a self-inspection and verified with the Company's controlling shareholders, actual controllers, all company directors, and senior management regarding relevant issues. The situation is hereby described as follows:

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.